Insys Therapeutics

(NASDAQ: INSY)
Healthcare  |  Biotechnology
1.07 0.01 0.94%
Stock Price | May 17, 2019, 3:59 p.m.
0 Followers
Bid: 0.0
Ask: 1.25
Prev. Close: 1.06
52 Week Low: 0.82
52 Week High: 11.65
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Insys Therapeutics Inc is a biotechnology company that develops and commercializes innovative drugs and novel drug delivery systems. The company maintains cannabinoid formulation and manufacturing, as well as sublingual spray drug delivery technology, to develop a portfolio of differentiated, wholly owned product candidates. Insys continues to specifically target oncology healthcare providers and practices. The company's sublingual spray delivery system is sourced, manufactured, and assembled by multiple third parties across the United States and Europe.

Read more Read less

Recently Viewed Tickers

Premium 420 Investor Cannabis Stock Survey

8 Comments
2 years ago

Free Cannabis Stock Survey - Public

2 years ago

Free Insider Buying Report - 12/1/15

3 years ago

Free Insider Buying Report - 11/24/15

3 years ago
3 years ago

Premium Livestox, Aug 13 2015...Update.

16 Comments
3 years ago
3 years ago
3 years ago